Cited by 670Adenosine and Purinergic SignalingBiochemical and Molecular Researchbioluminescence and chemiluminescence research

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

Open access

Pellegatti, Patrizia, Raffaghello, Lizzia, Bianchi, Giovanna, Piccardi, Federica, Pistoia, Vito, Di Virgilio, Francesco·2008·PLoS ONE

DOI 10.1371/journal.pone.0002599PMC PMC2440522

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: There is growing awareness that tumour cells build up a "self-advantageous" microenvironment that reduces effectiveness of anti-tumour immune response. While many different immunosuppressive mechanisms are likely to come into play, recent evidence suggests that extracellular adenosine acting at A2A receptors may have a major role in down-modulating the immune response as cancerous tissues contain elevated levels of adenosine and adenosine break-down products. While there is no doubt that all cells possess plasma membrane adenosine transporters that mediate adenosine uptake and may also allow its release, it is now clear that most of extracellularly-generated adenosine originates from the catabolism of extracellular ATP. METHODOLOGY/PRINCIPAL FINDINGS: Measurement of extracellular ATP is generally performed in cell supernatants by HPLC or soluble luciferin-luciferase assay, thus it generally turns out to be laborious and inaccurate. We have engineered a chimeric plasma membrane-targeted luciferase that allows in vivo real-time imaging of extracellular ATP. With this novel probe we have measured the ATP concentration within the tumour microenvironment of several experimentally-induced tumours. CONCLUSIONS/SIGNIFICANCE: Our results show that ATP in the tumour interstitium is in the hundreds micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targeted luciferase allows in vivo detection of high extracellular ATP concentration at tumour sites. On the contrary, tumour-free tissues show undetectable extracellular ATP levels. Extracellular ATP may be crucial for the tumour not only as a stimulus for growth but also as a source of an immunosuppressive agent such as adenosine. Our approach offers a new tool for the investigation of the biochemical composition of tumour milieu and for development of novel therapies based on the modulation of extracellular purine-based signalling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0002599

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2067 · Cited by 828
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 807
Adenosine, an endogenous distress signal, modulates tissue damage and repair
Fredholm, B. B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402132 · Cited by 704
P hysiological C ontrol of I mmune R esponse and I nflammatory T issue D amage by H ypoxia -I nducible F actors and A denosine A 2A R eceptors
Sitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697
ATP is a mediator of chemosensory transduction in the central nervous system
Gourine, A. V., Llaudet, E., Dale, N., & Spyer, K. M. (2005) · Nature · doi:10.1038/nature03690 · Cited by 537
Context, tissue plasticity, and cancer
Bissell, M. J., & LaBarge, M. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.013 · Cited by 517

Flagged first, then by citations

Show all 28 references

1 of the 28 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 670

P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
Shu, B., Sun, X., Bai, A., Zhang, C., Li, L., Enjyoji, K., JUNGER, W. G., Robson, S. C., & Wu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060184 · Cited by 132
Pharmacological targeting of ion channels for cancer therapy: In vivo evidences
Leanza, L., Managò, A., Zoratti, M., Gulbins, E., & Szabó, I. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.032 · Cited by 124
Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice
Wang, G., Xu, J., Zhao, J., Yin, W., Liu, D., Chen, W., & Hou, X. S. (2020) · Nature Communications · doi:10.1038/s41467-019-14046-9 · Cited by 121
Turn-On Supramolecular Host-Guest Nanosystems as Theranostics for Cancer
Cheng, H., Zhang, Y., Liu, Y., & Yoon, J. (2019) · Chem · doi:10.1016/j.chempr.2018.12.024 · Cited by 119
Autocrine regulation of TGF-β1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells
Takai, E., Tsukimoto, M., Harada, H., Sawada, K., Moriyama, Y., & Kojima, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.104976 · Cited by 115
Extracellular Purines Promote the Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells to the Osteogenic and Adipogenic Lineages
Ciciarello, M., Zini, R., Rossi, L., Salvestrini, V., Ferrari, D., Manfredini, R., & Lemoli, R. M. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0432 · Cited by 113
Production of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
Ghiringhelli, F., Bruchard, M., Chalmin, F., & Rébé, C. (2012) · BioMed Research International · doi:10.1155/2012/473712 · Cited by 120
Thermosensitive magnetic liposomes for alternating magnetic field-inducible drug delivery in dual targeted brain tumor chemotherapy
Lin, Y.-J., Chuang, E., Cheng, Y., Anilkumar, T. S., Chen, H., & Chen, J. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.05.055 · Cited by 115
Size Switchable Nanoclusters Fueled by Extracellular ATP for Promoting Deep Penetration and MRI‐Guided Tumor Photothermal Therapy
Zhou, Z., Liu, Y., Zhang, M., Li, C., Yang, R., Li, J., Qian, C., & Sun, M. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904144 · Cited by 112
Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer
Hofman, P. M., Cherfils‐Vicini, J., Bazin, M., Ilié, M., Juhel, T., Hébuterne, X., Gilson, É., Schmid‐Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 116
Connexin-43-dependent ATP release mediates macrophage activation during sepsis
Dosch, M., Zindel, J., Jebbawi, F., Mélin, N., Sánchez‐Taltavull, D., Stroka, D., Candinas, D., & Beldi, G. (2019) · eLife · doi:10.7554/elife.42670 · Cited by 113
Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications
Xu, D., Li, Y., Yin, S., & Huang, F. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00926b · Cited by 109
Revealing macropinocytosis using nanoparticles
Means, N., Elechalawar, C. K., Chen, W. R., Bhattacharya, R., & Mukherjee, P. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100993 · Cited by 109
Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATP In Vitro and In Vivo Using Multiple Endocytic Mechanisms
Qian, Y., Wang, X., Li, Y., Cao, Y., & Chen, X. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0118 · Cited by 107
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation
Kamata‐Sakurai, M., Narita, Y., Hori, Y., Nemoto, T., Uchikawa, R., Honda, M., Hironiwa, N., Taniguchi, K., Shida-Kawazoe, M., Metsugi, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0328 · Cited by 102
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
Su, X., Floyd, D. H., Hughes, A., Xiang, J., Schneider, J. G., Uluçkan, Ö., Heller, E., Deng, H., Zou, W., Craft, C. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38576 · Cited by 104
A phase I clinical trial demonstrates that nfP2X7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
Gilbert, S. M., Baird, A. G., Glazer, S., Barden, J. A., Glazer, A., Teh, L. C., & King, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15364 · Cited by 104
Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives
Roger, S., Jelassi, B., Couillin, I., Pelegrín, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 103
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
Giannuzzo, A., Saccomano, M., Napp, J., Ellegaard, M., Alves, F., & Novak, I. (2016) · International Journal of Cancer · doi:10.1002/ijc.30380 · Cited by 101
Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
Mello, P. D. A., Coutinho‐Silva, R., & Savio, L. E. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01526 · Cited by 108
The Roles of Neutrophils in Cytokine Storms
Chan, L., Karimi, N., Morovati, S., Alizadeh, K., Kakish, J. E., Vanderkamp, S., Fazel, F., Napoleoni, C., Alizadeh, K., Mehrani, Y., et al. (2021) · Viruses · doi:10.3390/v13112318 · Cited by 102
Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury
Ayata, C. K., Ganal-Vonarburg, S. C., Hockenjos, B., Willim, K., Vieira, R. P., Grimm, M., Robaye, B., Boeynaems, J. M., Virgilio, F. D., Pellegatti, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.049 · Cited by 97
Self-citation
Pulmonary Infection with Hypervirulent Mycobacteria Reveals a Crucial Role for the P2X7 Receptor in Aggressive Forms of Tuberculosis
Amaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 99
Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
Giuliani, A. L., Colognesi, D., Ricco, T., Roncato, C., Capece, M., Amoroso, F., Wang, Q., Marchi, E. D., Gartland, A., Virgilio, F. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107224 · Cited by 97
Metal-Free Nanoassemblies of Water-Soluble Photosensitizer and Adenosine Triphosphate for Efficient and Precise Photodynamic Cancer Therapy
Li, Z., Li, S., Guo, Y., Yuan, C., Yan, X., & Schanze, K. S. (2021) · ACS Nano · doi:10.1021/acsnano.0c09913 · Cited by 96
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
Young, C., & Górecki, D. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00248 · Cited by 97
Luciferase and Luciferin Co-immobilized Mesoporous Silica Nanoparticle Materials for Intracellular Biocatalysis
Sun, X., Zhao, Y., Lin, V. S. ‐., Slowing, I. I., & Trewyn, B. G. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2080168 · Cited by 94
The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway
Chadet, S., Jelassi, B., Wannous, R., Angoulvant, D., Chevalier, S., Besson, P., & Roger, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt493 · Cited by 94
Purinergic Signaling in the Hallmarks of Cancer
Campos‐Contreras, A. D. R., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2020) · Cells · doi:10.3390/cells9071612 · Cited by 103
The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications
Rotondo, J. C., Mazziotta, C., Lanzillotti, C., Stefani, C., Badiale, G., Campione, G., Martini, F., & Tognon, M. G. (2022) · Cancers · doi:10.3390/cancers14051116 · Cited by 98
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels
Kurth, I., Yamaguchi, N., Andreu-Agulló, C., Tian, H. S., Sridhar, S., Takeda, S., Gonsalves, F. C., Loo, J. M., Barlas, A., Manova-Todorova, K. O., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi7511 · Cited by 95
The P2Y2 Nucleotide Receptor Mediates the Proliferation and Migration of Human Hepatocellular Carcinoma Cells Induced by ATP
Xie, R., Xu, J., Wen, G., Jin, H. D., Liu, X., Yang, Y., Ji, B., Jiang, Y., Song, P., Dong, H. F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540047 · Cited by 92
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF V600E inhibitor-resistant metastatic melanoma cells
Martin, S., Dudek-Perić, A. M., Garg, A. D., Roose, H., Demirsoy, Ş., Eygen, S. V., Mertens, F., Vangheluwe, P., Vankelecom, H. E. J., & Agostinis, P. (2017) · Autophagy · doi:10.1080/15548627.2017.1332550 · Cited by 92
Modulation of innate and adaptive immunity by P2X ion channels
Virgilio, F. D., Sarti, A. C., & Grassi, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.026 · Cited by 95
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
Douguet, L., Hreich, S. J. D., Benzaquen, J., Seguin, L., Juhel, T., Dezitter, X., Duranton, C., Ryffel, B., Kanellopoulos, J., Delarasse, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20912-2 · Cited by 96
Gain an advantage from both sides: Smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration
Bai, S., Zhang, Y., Li, D., Shi, X., Lin, G., & Liu, G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101038 · Cited by 90
Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine
Pettengill, M. A., Robson, S. C., Tresenriter, M., Millán, J. L., Usheva, A., Bingham, T. C., Belderbos, M. E., Bergelson, I., Burl, S., Kampmann, B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484212 · Cited by 89
Cell surface-localized imaging and sensing
Jia, H., Zhu, Y., Duan, Q., & Wu, F. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00067e · Cited by 87
Targeting purine metabolism in ovarian cancer
Liu, J., Hong, S., Jiang, Y., Zhang, X., Wang, Y., Wang, H., Peng, J., & Hong, L. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01022-z · Cited by 93
P2Y2receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells
Jin, H., Eun, S. Y., Lee, J. S., Park, S. W., Lee, J. H., Chang, K. C., & Kim, H. J. (2014) · Breast Cancer Research · doi:10.1186/bcr3694 · Cited by 89
Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
Forte, G., Sorrentino, R., Montinaro, A., Luciano, A., Adcock, I. M., Maiolino, P., Arra, C., Cicala, C., Pinto, A., & Morello, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200744 · Cited by 86
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Hansen, R. R., Nielsen, C. K., Nasser, A., Thomsen, S. I. M., Eghorn, L. F., Pham, Y., Schulenburg, C., Syberg, S., Ding, M. L., Stojilković, S. S., et al. (2011) · Pain · doi:10.1016/j.pain.2011.03.024 · Cited by 86
Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells
Takai, E., Tsukimoto, M., Harada, H., & Kojima, S. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9411-x · Cited by 85
Altered purinergic receptor‐Ca2+ signaling associated with hypoxia‐induced epithelial‐mesenchymal transition in breast cancer cells
Azimi, I., Beilby, H., Davis, F. M., Marcial, D. L., Kenny, P. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.006 · Cited by 84
Defueling the cancer: ATP synthase as an emerging target in cancer therapy
Wang, T., Ma, F., & Qian, H. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.08.015 · Cited by 84
Immunoregulatory activity of adenosine and its role in human cancer progression
Muller-Haegele, S., Müller, L., & Whiteside, T. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.915739 · Cited by 82
Disruption of the Na+/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety
Huang, S., Dong, W., Lin, X., Xu, K., Li, K., Xiong, S., Wang, Z., Nie, X., & Bian, J.-S. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.018 · Cited by 83
ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells
Song, S., Jacobson, K., McDermott, K. M., Reddy, S. P., Cress, A. E., Tang, H., Dudek, S. M., Black, S. M., Garcia, J. G. N., Makino, A., et al. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00092.2015 · Cited by 81
Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer
Qin, J., Zhang, X., Tan, B., Zhang, S., Yin, C., Xue, Q., Zhang, Z., Ren, H., Chen, J., Liu, M., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0123 · Cited by 82
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling
Rossi, L., Salvestrini, V., Ferrari, D., Virgilio, F. D., & Lemoli, R. M. (2012) · Blood · doi:10.1182/blood-2012-04-422378 · Cited by 83
Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase
Wang, X., Li, Y., Qian, Y., Cao, Y., Shriwas, P., Zhang, H., & Chen, X. (2017) · Oncotarget · doi:10.18632/oncotarget.21231 · Cited by 80
Extracellular and macropinocytosis internalized ATP work together to induce epithelial–mesenchymal transition and other early metastatic activities in lung cancer
Cao, Y., Wang, X., Li, Y., Evers, M., Zhang, H., & Chen, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0973-0 · Cited by 77
Identification of an Arabidopsis Plasma Membrane–Located ATP Transporter Important for Anther Development
Rieder, B., & Neuhaus, H. E. (2011) · The Plant Cell · doi:10.1105/tpc.111.084574 · Cited by 77
P2X7 receptors: role in bone cell formation and function
Agrawal, A., & Gartland, A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0226 · Cited by 76
Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models
Humeau, J., Lévesque, S., Kroemer, G., & Pol, J. G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8885-3_21 · Cited by 84
Purinergic signalling in the pancreas in health and disease
Burnstock, G., & Novak, I. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0434 · Cited by 79
Extracellular ATP promotes breast cancer invasion and epithelial‐mesenchymal transition via hypoxia‐inducible factor 2α signaling
Yang, H., Geng, Y., Wang, P., Zhou, Y., Yang, H. K., Huo, Y., Zhang, H., Li, Y., He, H., Tian, X., et al. (2019) · Cancer Science · doi:10.1111/cas.14086 · Cited by 73
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 83
P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain
Krajewski, J. L. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00934-2 · Cited by 75
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Bao, X., & Xie, L. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02430-1 · Cited by 76
P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment
Joo, Y. N., Jin, H., Eun, S. Y., Park, S. W., Chang, K. C., & Kim, H. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2427 · Cited by 74
Boronic Acid-Appended Molecular Glues for ATP-Responsive Activity Modulation of Enzymes
Okuro, K., Sasaki, M., & Aida, T. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02664 · Cited by 74
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids
Helenius, M., Jalkanen, S., & Yegutkin, G. G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.001 · Cited by 73
PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions
Gómez‐Villafuertes, R., García-Huerta, P., Díaz‐Hernandéz, J. I., & Miras‐Portugal, M. T. (2015) · Scientific Reports · doi:10.1038/srep18417 · Cited by 72
Tumor Therapy Strategies Based on Microenvironment‐Specific Responsive Nanomaterials
Zhang, Z., Ding, C., Sun, T., Wang, L., & Chen, C. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300153 · Cited by 72
Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints
Gourdin, N., Bossennec, M., Rodriguez, C., Viganó, S., Machon, C., Jandus, C., Bauché, D., Faget, J., Durand, I., Chopin, N., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2405 · Cited by 72
Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
Liu, J., Zhang, K., Cheng, L., Zhu, H., & Xu, T. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s237393 · Cited by 75
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
Giatromanolaki, A. N., Kouroupi, M., Pouliliou, S., Mitrakas, A. G., Hasan, F., Pappa, A., & Koukourakis, M. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118389 · Cited by 71
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment
Mimoto, F., Tatsumi, K., Shimizu, S., Kadono, S., Haraya, K., Nagayasu, M., Suzuki, Y., Fujii, E., Kamimura, M., Hayasaka, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108542 · Cited by 71
Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Friedle, S. A., Curet, M., & Watters, J. J. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753530 · Cited by 74
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Maggs, L., Sadagopan, A., Moghaddam, A. S., & Ferrone, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.07.006 · Cited by 76
In situ cell-type-specific cell-surface proteomic profiling in mice
Shuster, S. A., Li, J., Chon, U., Sinantha-Hu, M. C., Luginbuhl, D. J., Udeshi, N. D., Carey, D. K., Takeo, Y. H., Xie, Q., Xu, C., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.025 · Cited by 70
The Clinical Significance of CD73 in Cancer
Bach, N., Winzer, R., Tolosa, E., Fiedler, W., & Brauneck, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411759 · Cited by 74
Imaging extracellular ATP with a genetically-encoded, ratiometric fluorescent sensor
Conley, J. M., Radhakrishnan, S., Valentino, S. A., & Tantama, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187481 · Cited by 73
Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer
Wang, Q., Li, M., Gan, Y., Jiang, S., Qiao, J., Zhang, W., Fan, Y., Shen, Y., Song, Y., Meng, Z., et al. (2020) · Theranostics · doi:10.7150/thno.38704 · Cited by 69
P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway
Li, W.-H., Qiu, Y., Zhang, H., Tian, X., & Fang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133165 · Cited by 69
P2X7 receptor activation induces inflammatory responses in salivary gland epithelium
Woods, L. T., Camden, J. M., Batek, J. M., Petris, M. J., Erb, L., & Weisman, G. A. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00072.2012 · Cited by 68
P2X7 receptor drives Th1 cell differentiation and controls the follicular helper T cell population to protect against Plasmodium chabaudi malaria
de Salles, É. M., de Menezes, M. N., Siqueira, R., da Silva, H. B., Amaral, E. P., Castillo-Méndez, S. I., Cunha, I., Cassado, A. D. A., Vieira, F. S., Olivieri, D. N., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006595 · Cited by 68
PARACRINE STIMULATION OF P2X7 RECEPTOR BY ATP ACTIVATES A PROLIFERATIVE PATHWAY IN OVARIAN CARCINOMA CELLS
Vázquez‐Cuevas, F. G., Martínez-Ramírez, A. S., Robles-Martínez, L., Garay, E., García-Carrancá, A. M., Pérez‐Montiel, D., Castañeda-García, C., & Arellano, R. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24867 · Cited by 67
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling
Avanzato, D., Genova, T., Fiorio, A., Bernardini, M., Bianco, S., Bussolati, B., Mancardi, D., Giraudo, E., Maione, F., Cassoni, P., et al. (2016) · Scientific Reports · doi:10.1038/srep32602 · Cited by 69
Exploiting cancer’s drinking problem: regulation and therapeutic potential of macropinocytosis
Puccini, J., Badgley, M. A., & Bar‐Sagi, D. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.004 · Cited by 67
The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways
Xu, M., Almasi, S., Yang, Y., Yan, C. W., Sterea, A. M., Syeda, A. K. R., Shen, B. Q., Clements, D. R., Huang, P., Gujar, S. A., et al. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.02.010 · Cited by 70
Bioluminescence Imaging Applications in Cancer: A Comprehensive Review
AlSawaftah, N., Farooq, A., Dhou, S., & Majdalawieh, A. F. (2020) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2995124 · Cited by 65
Osteocytes and Bone Metastasis
Riquelme, M. A., Cardenas, E. R., & Jiang, J. X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.567844 · Cited by 65
P2X7 receptor antagonism in the treatment of cancers
Roger, S., & Pelegrı́n, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.583918 · Cited by 69
P2X7 Variants in Oncogenesis
Pegoraro, A., Marchi, E. D., & Adinolfi, E. (2021) · Cells · doi:10.3390/cells10010189 · Cited by 67
Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints
Baghbani, E., Noorolyai, S., Shanehbandi, D., Mokhtarzadeh, A., Maleki, L. A., Khaze, V., Brunetti, O., Rahmani, S., Shadbad, M. A., Baghbanzadeh, A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119826 · Cited by 64
ATP and P2X Purinoceptors in Urinary Tract Disorders
Ford, A. P. D. W., & Cockayne, D. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_22 · Cited by 64
Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells
Ledur, P. F., Villodre, E. S., Paulus, R., Cruz, L. A., Flores, D. G., & Lenz, G. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9252-9 · Cited by 66
Extracellular NAD+: a danger signal hindering regulatory T cells
Adriouch, S., Haag, F., Boyer, O., Séman, M., & Koch‐Nolte, F. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.011 · Cited by 68
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors
Romagnani, A., Rottoli, E., Mazza, E. M. C., Rezzonico-Jost, T., Conti, B. D. P., Proietti, M., Perotti, M., Civanelli, E., Perruzza, L., Catapano, A. L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3807 · Cited by 63
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 63
Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor
Martínez-Cuesta, M. Á., Blanch‐Ruiz, M. A., Ortega‐Luna, R., Sánchez‐López, A., & Álvarez, Á. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228454 · Cited by 68
Emerging Roles of P2X Receptors in Cancer
Adinolfi, E., Capece, M., Amoroso, F., Marchi, E. D., & Franceschini, A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141012172913 · Cited by 62
Metabolic Reprogramming in Cancer is Induced to Increase Proton Production.
Sun, H., Zhou, Y., Skaro, M., Wu, Y.-R., Qu, Z.-X., Mao, F., Zhao, S.-W., & Xu, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3392 · Cited by 54
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 63
P2 receptors and immunity
Rayah, A., Kanellopoulos, J., & Virgilio, F. D. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.07.006 · Cited by 63
P2Y12 Receptors in Tumorigenesis and Metastasis
Ballerini, P., Dovizio, M., Bruno, A., Tacconelli, S., & Patrignani, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00066 · Cited by 61
The G protein-coupled P2Y6 receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis
Placet, M., Arguin, G., Molle, C. M., Babeu, J., Jones, C. M., Carrier, J. C., Robaye, B., Geha, S., Boudreau, F., & Gendron, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.02.008 · Cited by 61
Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production
Park, M., Kim, J., Phương, N. T. T., Park, J. G., Park, J., Kim, Y., Baek, M. C., Lim, S., & Kang, K. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-47734-z · Cited by 62

Authors: Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F.
Affiliations: University of Ferrara (IT)
Istituto Giannina Gaslini (IT)
ORCID: Raffaghello, Lizzia
Bianchi, Giovanna
Pistoia, Vito
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2008-07-09
Volume: 3
Issue: 7
Pages: e2599
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0002599
PMC: PMC2440522
OpenAlex: W2070663123
Cited by: 668
References: 28
Citations by year: 2026: 31 · 2025: 40 · 2024: 29 · 2023: 62 · 2022: 51 · 2021: 58 · 2020: 66 · 2019: 42 · 2018: 37 · 2017: 34 · 2016: 33 · 2015: 25 · 2014: 36 · 2013: 28 · 2012: 40
FWCI: 11.40
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Funders: Fondazione Italiana per la Lotta al Neuroblastoma
Associazione Italiana per la Ricerca sul Cancro (GGP06070)
Università degli Studi di Ferrara
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
Keywords: extracellular ATP, tumor microenvironment, in vivo imaging, adenosine, adenosine A2A receptor, immunosuppression, ATP catabolism, adenosine transporter
MeSH terms: Adenosine Triphosphate, Animals, Cell Membrane, Extracellular Space, Humans, Luciferases, Luminescent Measurements, Mice, Nude, Neoplasms, Cell Line, Tumor, Luminescent Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks